Based on the Aequus Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Aequus Pharmaceuticals Inc is not available over the next 12 months. Aequus Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aequus Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Aequus Pharmaceuticals Inc’s stock price was CAD 0.01. Aequus Pharmaceuticals Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -80.00% over the last year.
No recent analyst target price found for Aequus Pharmaceuticals Inc
No recent average analyst rating found for Aequus Pharmaceuticals Inc
Company Overview Aequus Pharmaceuticals Inc
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma. It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Read Less
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma...Read More
Frequently Asked Questions About Aequus Pharmaceuticals Inc (AQS:CA) Stock
Stock Target Advisor's fundamental analysis for Aequus Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on AQS:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AQS:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AQS:CA's stock to indicate if its overvalued.
The last closing price of AQS:CA's stock was CAD 0.01.
The most recent market capitalization for AQS:CA is CAD 0.66M.
Unfortunately we do not have enough analyst data on AQS:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aequus Pharmaceuticals Inc's stock.
As per our most recent records Aequus Pharmaceuticals Inc has 0 Employees.
Aequus Pharmaceuticals Inc's registered address is 200 Granville Street, Vancouver, BC, Canada, V6C 1S4.
You can get more information about it from Aequus Pharmaceuticals Inc's website at https://www.aequuspharma.ca.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Aequus Pharmaceuticals Inc (AQS:CA) Stock
Stock Target Advisor's fundamental analysis for Aequus Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on AQS:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AQS:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AQS:CA's stock to indicate if its overvalued.
The last closing price of AQS:CA's stock was CAD 0.01.
The most recent market capitalization for AQS:CA is CAD 0.66M.
Unfortunately we do not have enough analyst data on AQS:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aequus Pharmaceuticals Inc's stock.
As per our most recent records Aequus Pharmaceuticals Inc has 0 Employees.
Aequus Pharmaceuticals Inc's registered address is 200 Granville Street, Vancouver, BC, Canada, V6C 1S4.
You can get more information about it from Aequus Pharmaceuticals Inc's website at https://www.aequuspharma.ca.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AQS:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
